- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有19家主力机构披露2025-12-31报告期持股数据，持仓量总计1.13亿股，占流通A股47.13%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了40%的股票
技术面评分前10的股票
近期的平均成本为11.05元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为11.05元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.05","date":1777276291,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.04.28","stock":"-0.72","trade":"0.26","ind":"-1.10"},{"date":"2026.04.27","stock":"0.45","trade":"-0.18","ind":"0.37"},{"date":"2026.04.24","stock":"2.41","trade":"-0.04","ind":"-0.69"},{"date":"2026.04.23","stock":"-1.73","trade":"-0.87","ind":"-0.88"},{"date":"2026.04.22","stock":"-1.44","trade":"0.13","ind":"1.30"},{"date":"2026.04.21","stock":"0.18","trade":"-0.57","ind":"0.10"},{"date":"2026.04.20","stock":"-0.80","trade":"0.15","ind":"0.55"},{"date":"2026.04.17","stock":"-3.45","trade":"-1.52","ind":"0.60"},{"date":"2026.04.16","stock":"2.66","trade":"-0.13","ind":"2.05"},{"date":"2026.04.15","stock":"-0.44","trade":"2.03","ind":"-0.97"},{"date":"2026.04.14","stock":"-1.39","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"1.05","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"-0.18","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-3.31","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"1.46","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"1.31","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-4.18","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"0.08","trade":"0.62","ind":"-1.60"},{"date":"2026.04.01","stock":"2.40","trade":"2.36","ind":"1.70"},{"date":"2026.03.31","stock":"-2.50","trade":"-0.69","ind":"-1.81"},{"date":"2026.03.30","stock":"-0.42","trade":"1.18","ind":"-0.25"}]
古汉医药,深证成指,中药指数
压力支撑
该股压力位为11.01元，支撑位为10.79元。
[{"text":"\u538b\u529b\u4f4d","value":"11.01","date":1777305600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.79","date":1777305600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.9资金面打败了61%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月28日 20:30
| 机构今日流向(万元) | -75.10 | 机构5日流向(万元) | -2741.00 |
| 机构10日流向(万元) | -7414.69 | 机构20日流向(万元) | -15992.19 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加268.56万股，其中基金净增仓1家，主力净增仓12家，有一定的中长期投资价值。
截止2025-12-31，共19家主力机构（一般法人5家，基金14家），持仓量总计11281.29万股，占流通A股47.13%
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 0.10万股
减仓：0家 ，减持 0万股
新出现在主力名单中：16家 ，持有6248.88万股
从主力名单中消失：4家 ，原持有5980.42万股
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 0.10万股
减仓：0家 ，减持 0万股
新出现在主力名单中：16家 ，持有6248.88万股
从主力名单中消失：4家 ，原持有5980.42万股
消息面诊股
诊断结果：5.7消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 股东追踪|MORGAN STANLEY & CO.
2026-04-28 - 古汉医药：公司始终聚焦主业经营，扎实推进生产经营与
2026-04-27 - 古汉医药（截止2026年3月31日）股东人数为14
2026-04-27 - 古汉医药：2026年一季度净利润亏损681.35万
2026-04-27 - 2025年中药上市公司解析：业绩分化显著，整体增长
2026-04-22 - 古汉医药：恒昌药业销售能力弥补公司销售渠道短板
2026-04-02 - 古汉医药2025年营收3.38亿元 同比减亏近六成
2026-04-02 - 财报速递：古汉医药2025年全年净亏损5051.6
2026-04-02 - 古汉医药（截止2026年2月28日）股东人数为15
2026-03-30 - 古汉医药全年营业收入3.38亿元，同比下降1.61
2026-03-30
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-03-31 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-31 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-30 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-19 |
| 一般消息 | 高管变动 | 工作原因 | 2025-11-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-24 |
| 一般消息 | 高管变动 | 因工作变动 | 2025-09-22 |
| 一般消息 | 高管变动 | 因工作变动 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-08-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.8行业面打败了78%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.28","price":"-1.10","value":"0.26"},{"date":"2026.04.27","price":"0.37","value":"-0.18"},{"date":"2026.04.24","price":"-0.69","value":"-0.04"},{"date":"2026.04.23","price":"-0.88","value":"-0.87"},{"date":"2026.04.22","price":"1.30","value":"0.13"},{"date":"2026.04.21","price":"0.10","value":"-0.57"},{"date":"2026.04.20","price":"0.55","value":"0.15"},{"date":"2026.04.17","price":"0.60","value":"-1.52"},{"date":"2026.04.16","price":"2.05","value":"-0.13"},{"date":"2026.04.15","price":"-0.97","value":"2.03"},{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"},{"date":"2026.04.01","price":"1.70","value":"2.36"},{"date":"2026.03.31","price":"-1.81","value":"-0.69"},{"date":"2026.03.30","price":"-0.25","value":"1.18"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康惠股份 | 24.78% | -1.33% | 6.0分 |
| 2 | 沃华医药 | 15.63% | -3.86% | 4.8分 |
| 3 | 万邦德 | 8.71% | 7.03% | 6.8分 |
| 4 | 益佰制药 | 7.12% | -12.47% | 4.2分 |
| 5 | ST葫芦娃 | 6.31% | 1.62% | 4.9分 |
| 6 | 汉森制药 | 6.09% | 9.51% | 6.2分 |
| 8 | 天士力 | 5.22% | 7.09% | 6.2分 |
| 10 | 九芝堂 | 4.03% | 4.80% | 6.4分 |
| 12 | 新光药业 | 3.48% | 2.03% | 5.8分 |
| 14 | 葵花药业 | 2.15% | 4.82% | 5.5分 |
| 16 | 众生药业 | 1.39% | 5.70% | 6.1分 |
| 18 | 康缘药业 | 0.94% | 0.58% | 5.9分 |
| 20 | 三力制药 | 0.54% | 0.45% | 5.8分 |
| 22 | 广誉远 | 0.18% | -3.53% | 4.7分 |
| 24 | ST香雪 | -0.11% | -7.38% | 3.8分 |
| 26 | 羚锐制药 | -0.13% | 4.78% | 6.8分 |
| 28 | 白云山 | -0.35% | 0.88% | 5.8分 |
| 30 | 步长制药 | -0.48% | 0.00% | 5.8分 |
| 32 | 恩威医药 | -0.87% | -2.25% | 6.2分 |
| 34 | ST百灵 | -0.99% | -0.20% | 5.0分 |
| 36 | 华森制药 | -1.42% | 0.29% | 5.0分 |
| 38 | 粤万年青 | -2.04% | -1.58% | 5.1分 |
| 40 | 康美药业 | -2.84% | -1.72% | 4.4分 |
| 42 | 同仁堂 | -3.09% | -1.69% | 4.6分 |
| 44 | 上海凯宝 | -3.21% | -3.54% | 4.6分 |
| 46 | 中恒集团 | -3.53% | -1.20% | 4.9分 |
| 48 | 华神科技 | -3.85% | -0.25% | 5.8分 |
| 50 | 东阿阿胶 | -4.63% | 3.06% | 5.7分 |
| 52 | 红日药业 | -5.35% | -2.33% | 4.6分 |
| 54 | 珍宝岛 | -6.72% | -1.62% | 4.2分 |
| 56 | 振东制药 | -7.74% | -3.21% | 4.8分 |
| 58 | 太极集团 | -7.79% | -3.72% | 4.7分 |
| 60 | 达仁堂 | -8.34% | -1.94% | 5.5分 |
| 62 | 佛慈制药 | -9.43% | -2.39% | 5.2分 |
| 64 | 特一药业 | -11.63% | -6.35% | 5.1分 |
| 66 | 盘龙药业 | -12.86% | -4.33% | 4.7分 |
| 68 | 嘉应制药 | -18.23% | -15.22% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-12-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 51/107 ， 40/107。
[{"date":"2025-12-31","value":"-8.82","vol":"5.45"},{"date":"2025-09-30","value":"-2.51","vol":"4.81"},{"date":"2025-06-30","value":"-2.91","vol":"4.04"},{"date":"2025-03-31","value":"-2.75","vol":"2.25"},{"date":"2024-12-31","value":"-18.98","vol":"4.87"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-8.82 | -2.51 | -2.91 | -2.75 | -18.98 |
| 行业(%) | 5.45 | 4.81 | 4.04 | 2.25 | 4.87 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"44.75","vol":"54.36"},{"date":"2025-09-30","value":"46.67","vol":"53.26"},{"date":"2025-06-30","value":"44.93","vol":"53.79"},{"date":"2025-03-31","value":"47.45","vol":"54.43"},{"date":"2024-12-31","value":"46.81","vol":"53.69"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
44.75 | 46.67 | 44.93 | 47.45 | 46.81 |
| 行业(%) | 54.36 | 53.26 | 53.79 | 54.43 | 53.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/107 ， 8/107。
[{"date":"2025-12-31","value":"-1.61","vol":"-4.28"},{"date":"2025-09-30","value":"3.97","vol":"-7.81"},{"date":"2025-06-30","value":"-2.87","vol":"-7.74"},{"date":"2025-03-31","value":"-15.40","vol":"-7.31"},{"date":"2024-12-31","value":"-15.18","vol":"-6.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.61 | 3.97 | -2.87 | -15.40 | -15.18 |
| 行业(%) | -4.28 | -7.81 | -7.74 | -7.31 | -6.13 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"59.74","vol":"-81.72"},{"date":"2025-09-30","value":"47.91","vol":"-2.50"},{"date":"2025-06-30","value":"26.61","vol":"2.58"},{"date":"2025-03-31","value":"-96.23","vol":"-37.35"},{"date":"2024-12-31","value":"-596.98","vol":"-148.45"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
59.74 | 47.91 | 26.61 | -96.23 | -596.98 |
| 行业(%) | -81.72 | -2.50 | 2.58 | -37.35 | -148.45 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 45/107 ， 39/107。
[{"date":"2025-12-31","value":"0.35","vol":"0.50"},{"date":"2025-09-30","value":"0.23","vol":"0.35"},{"date":"2025-06-30","value":"0.14","vol":"0.24"},{"date":"2025-03-31","value":"0.06","vol":"0.13"},{"date":"2024-12-31","value":"0.32","vol":"0.50"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.35 | 0.23 | 0.14 | 0.06 | 0.32 |
| 行业(次) | 0.50 | 0.35 | 0.24 | 0.13 | 0.50 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.59","vol":"2.35"},{"date":"2025-09-30","value":"1.00","vol":"1.72"},{"date":"2025-06-30","value":"0.62","vol":"1.17"},{"date":"2025-03-31","value":"0.27","vol":"0.60"},{"date":"2024-12-31","value":"1.43","vol":"2.41"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.59 | 1.00 | 0.62 | 0.27 | 1.43 |
| 行业(次) | 2.35 | 1.72 | 1.17 | 0.60 | 2.41 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 50/107 ， 51/107。
[{"date":"2025-12-31","value":"-3.70","vol":"20.71"},{"date":"2025-09-30","value":"2.65","vol":"10.53"},{"date":"2025-06-30","value":"109.74","vol":"22.82"},{"date":"2025-03-31","value":"-82.48","vol":"2.07"},{"date":"2024-12-31","value":"2.74","vol":"22.07"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -3.70 | 2.65 | 109.74 | -82.48 | 2.74 |
| 行业 | 20.71 | 10.53 | 22.82 | 2.07 | 22.07 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.44","vol":"0.78"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.62","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.07","vol":"1.48"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.44 | - | 1.62 | - | 1.07 |
| 行业 | 0.78 | 0.00 | 1.03 | 0.00 | 1.48 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/107 ， 14/107。
[{"date":"2025-12-31","value":"1.88","vol":"3.05"},{"date":"2025-09-30","value":"2.65","vol":"3.09"},{"date":"2025-06-30","value":"2.12","vol":"2.94"},{"date":"2025-03-31","value":"2.02","vol":"3.03"},{"date":"2024-12-31","value":"2.12","vol":"2.92"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.88 | 2.65 | 2.12 | 2.02 | 2.12 |
| 行业 | 3.05 | 3.09 | 2.94 | 3.03 | 2.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.30","vol":"2.27"},{"date":"2025-09-30","value":"1.81","vol":"2.24"},{"date":"2025-06-30","value":"1.49","vol":"2.15"},{"date":"2025-03-31","value":"1.47","vol":"2.24"},{"date":"2024-12-31","value":"1.56","vol":"2.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.30 | 1.81 | 1.49 | 1.47 | 1.56 |
| 行业 | 2.27 | 2.24 | 2.15 | 2.24 | 2.13 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/107 ， 20/107。
[{"date":"2025-12-31","value":"38.22","vol":"31.37"},{"date":"2025-09-30","value":"38.04","vol":"31.59"},{"date":"2025-06-30","value":"42.14","vol":"32.44"},{"date":"2025-03-31","value":"42.76","vol":"31.90"},{"date":"2024-12-31","value":"40.67","vol":"32.73"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.22 | 38.04 | 42.14 | 42.76 | 40.67 |
| 行业(%) | 31.37 | 31.59 | 32.44 | 31.90 | 32.73 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.62","vol":"0.65"},{"date":"2025-09-30","value":"0.62","vol":"0.76"},{"date":"2025-06-30","value":"0.73","vol":"0.75"},{"date":"2025-03-31","value":"0.75","vol":"0.74"},{"date":"2024-12-31","value":"0.69","vol":"0.76"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.62 | 0.62 | 0.73 | 0.75 | 0.69 |
| 行业(%) | 0.65 | 0.76 | 0.75 | 0.74 | 0.76 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.51","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]